𝔖 Bobbio Scriptorium
✦   LIBER   ✦

C-ErbB-2 Oncoprotein Immunostaining In Serous Effusions

✍ Scribed by V. ASCOLI; C. CARNOVALE. SCALZO; F. NARDI


Book ID
108705747
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
784 KB
Volume
4
Category
Article
ISSN
0956-5507

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Value of Ki67 immunostain in identificat
✍ Husain Saleh; Paula Bober; Pamela Tabaczka πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 2 views

The distinction between malignant and benign serous effusions continues to be a challenging and a frequent problem to cytopathologists. Recently, immunostains employing various antibodies have improved the diagnostic accuracy of malignant effusions. We investigated the usefulness of Ki67 (MIB1) anti

Retrospective c-erbB-2 immunostaining in
✍ M. Jorda; P. Ganjei; M. Nadji πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 334 KB

## Abstract Fifty fine‐needle aspiration cytologies of breast that were diagnosed as carcinomas were retrieved from the files and retrospectively evaluated for the expression of __c__‐__erb__B‐2 oncoprotein using standard immunocytochemical methods. Corresponding histologic sections of all tumors w

C-erbB-2 oncoprotein in screen-detected
✍ Salma Soomro; P. Taylor; H. M. Shepard; M. Feldmann; H. D. Sinnett; S. Shousha πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 344 KB

This study was aimed at comparing screen-detected and symptomatic breast carcinomas with regard to the prevalence of positive immunostaining for c-erb-B-2 oncoprotein. Paraffin sections of 8 I breast carcinomas detected through the National Screening Programme were examined for the over-expression o